Paschoal, Elisabete
Gooden, Tiffany E.
Olmos, Rodrigo D.
Lotufo, Paulo A.
Benseñor, Isabela M.
Manaseki-Holland, Semira
Lip, Gregory Y. H.
Thomas, G. Neil
Jolly, Kate
Lancashire, Emma
Lane, Deirdre A.
Greenfield, Sheila
Goulart, Alessandra C.
Arasalingam, Ajini
Beane, Abi
Brocklehurst, Peter
Cheng, Kar Keung
El-Bouri, Wahbi
Feng, Mei
Guo, Yutao
Guruparan, Mahesan
Gusso, Gustavo
Haniffa, Rashan
Humphreys, Lindsey
Jowett, Sue
Kodippily, Chamira
Kumarendran, Balachandran
Li, Xuewen
Li, Yan-guang
Lobban, Trudie
Moore, David
Nirantharakumar, Krishnarajah
Pirasanth, Paskaran
Powsiga, Uruthirakumar
Romagnolli, Carla
Santos, Itamar S.
Shantsila, Alena
Sheron, Vethanayagan Antony
Shribavan, Kanesamoorthy
Szmigin, Isabelle
Subaschandren, Kumaran
Surenthirakumaran, Rajendra
Tai, Meihui
Thavarajah, Bamini
Toippa, Timo
Varella, Ana C.
Wang, Hao
Wang, Jingya
Zhang, Hui
Zhong, Jiaoyue
,
Funding for this research was provided by:
National Institute for Health Research (project reference 17/63/121)
Article History
Received: 21 March 2022
Accepted: 29 October 2022
First Online: 22 December 2022
Declarations
:
: This research was approved by the local Ethics Committee from the Hospital Universitario of the University of Sao Paulo (Reference: 94732318.6.0000.0076) and the National Ethical Committees for International Research in Brazil (Reference: 3.301.920) with subsequent review and approval by the University of Birmingham ethics committee (Reference: ERN_19-1898). All participants gave informed written consent and provided their signature through an electronic form.
: Not applicable.
: GYHL: Consultant and speaker for BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received personally.DAL: Investigator-initiated educational grants from Bristol-Myers Squibb (BMS), speaker for Bayer, Boehringer Ingeheim, and BMS/Pfizer; Consultant for BMS, and Boehringer Ingelheim.Other authors: Declare no conflict of interest.